MedPath

Prevention of Insomnia Using a Stepped Care Model in Adults

Not Applicable
Recruiting
Conditions
Sleep Disturbance
Interventions
Behavioral: Cognitive behavioral prevention program for insomnia (CBP-I)
Registration Number
NCT06156293
Lead Sponsor
Chinese University of Hong Kong
Brief Summary

Insomnia is one of the most common sleep disorders and affects approximately 10 - 40% of the population across different age groups in Hong Kong. Our previous study has shown that insomnia can be prevented through a brief cognitive behavioral prevention program in adolescents. However, there is very limited data in the adult population.

Current study aims to evaluate a digital sleep-focused platform which consists of different intervention plan according to user's insomnia severity level and employed a stepped care model. Thus, the effectiveness of the stepped care model will be evaluated in a real world setting using stepped wedge cluster randomized controlled design to evaluate potential preventive effect on adults who only with mild insomnia symptoms. The program will be rolled out to different districts in Hong Kong sequentially in 18 districts over 4 steps with a equally spaced time periods. The primary aim of this study is to evaluate the effects of a stepped-care CBT-I model in improving sleep and prevent the incidence of insomnia among participants with mild insomnia.

Detailed Description

This interventional study will be a multicenter, assessor-blinded, pragmatic stepped-wedge cluster randomized controlled trial. A total of 18 districts will be included in the study and the randomization will be carried out based on the districts. The stepped-care CBT-I intervention will be sequentially rolled out to the 4-6 districts per step according to a computer-generated random number while the remaining clusters will continue to stay unexposed to the CBT-I intervention over the control period. Therefore after 4-step exposure, all clusters will receive the stepped-care CBT-I intervention. A total of 3 follow-up assessments (post intervention, 3-month and 12-month follow up) will be conducted to assess the effectiveness and long-term effects of the stepped care model.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1016
Inclusion Criteria
  1. Chinese adults aged 18-70 years old,
  2. The score of Insomnia Severity Index < 10.
Read More
Exclusion Criteria
  1. present with psychotic disorders such as bipolar disorder and schizophrenia,
  2. present with severe depression or suicidal ideation,
  3. present with neurodegenerative diseases that prevent participant from completing the intervention (e.g., dementia and Parkinson's disease).
  4. unable to provide consent
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Stepped-care CBT-I groupCognitive behavioral prevention program for insomnia (CBP-I)A total of 3 steps of sleep focused intervention will be provided, with the objectives to increase the awareness of sleep health, increase sleep literacy, establish good sleep hygiene and treat insomnia. Step 1: self-help digital sleep focused program; Step 2: guided intervention; Step 3: individualized consultation.
Primary Outcome Measures
NameTimeMethod
Insomnia severity indexPost-intervention (ranging from 8 weeks to 24 weeks, depending on the treatment level), 3-month postintervention and 12-month post-intervention follow up

The primary outcome will be the perceived insomnia severity measured by Insomnia Severity Index (ISI).

Secondary Outcome Measures
NameTimeMethod
Severity of depressionPost-intervention (ranging from 8 weeks to 24 weeks, depending on the treatment level), 3-month post-intervention and 12-month post-intervention follow up

Patient Health Questionnaire-9 (PHQ-9) will be used to measure the severity of depression.

Health-related quality of lifePost-intervention (ranging from 8 weeks to 24 weeks, depending on the treatment level), 3-month post-intervention and 12-month post-intervention follow up

The health-related quality of life (HRQoL) will be measured by the EuroQol-5D (EQ).

Chronic insomnia diagnosisPost-intervention (ranging from 8 weeks to 24 weeks, depending on the treatment level), 3-month post-intervention and 12-month post-intervention follow up

A checklist based on Diagnostic and statistical manual of mental disorders will be implemented to measure the incidence of chronic insomnia.

Patient-report clinical global impressionPost-intervention (ranging from 8 weeks to 24 weeks, depending on the treatment level), 3-month post-intervention and 12-month post-intervention follow up

A single-item CGI will be used to ask the participant whether they experience sleep improvement or change over the past week or not.

Subjective sleep as measured by sleep diaryPost-intervention (ranging from 8 weeks to 24 weeks, depending on the treatment level), 3-month post-intervention and 12-month post-intervention follow up

Self-report sleep diary will be used to record subjective sleep of the participants including total time in bed, sleep onset latency, total sleep duration, sleep efficiency and wake after sleep onset.

Healthcare resource usePost-intervention (ranging from 8 weeks to 24 weeks, depending on the treatment level), 3-month post-intervention and 12-month post-intervention follow up

The use and expense of sleep-promoting medication, psychotherapy, and other complementary treatments for sleep improvement will be collected from individual participants using a self-developed questionnaire, with a focus on their healthcare resource utilization.

Medication usagePost-intervention (ranging from 8 weeks to 24 weeks, depending on the treatment level), 3-month post-intervention and 12-month post-intervention follow up

A checklist will be used to measure the subject's medication usage change.

Clinical global impressionPost-intervention (ranging from 8 weeks to 24 weeks, depending on the treatment level), 3-month post-intervention and 12-month post-intervention follow up

Clinical Global Impression (CGI) will be used to assess the insomnia severity over time.

Severity of anxietyPost-intervention (ranging from 8 weeks to 24 weeks, depending on the treatment level), 3-month post-intervention and 12-month post-intervention follow up

General Anxiety Disorder-7 (GAD-7) will be used to measure the severity of anxiety.

Sleep durationPost-intervention (ranging from 8 weeks to 24 weeks, depending on the treatment level), 3-month post-intervention and 12-month post-intervention follow up

Two self-report questions will be used to record the sleep duration during weekdays and weekends of the participants.

Work and social functioningPost-intervention (ranging from 8 weeks to 24 weeks, depending on the treatment level), 3-month post-intervention and 12-month post-intervention follow up

A 5-item questionnaire developed from Work and Social Adjustment Scale (WSAS) will be used to measure the daytime functioning of the participants such as ability to work, home management, social and private leisure activities, and close relationship maintenance

Trial Locations

Locations (1)

Department of Psychiatry, the Chinese University of Hong Kong

🇨🇳

Hong Kong, China

© Copyright 2025. All Rights Reserved by MedPath